Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX1 | P51575 | 2/20 | 0.64 |
| ▸ | P2RX4 | Q99571 | 2/20 | 0.64 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.64 |
| ▸ | TMPRSS4 | Q9NRS4 | 2/20 | 0.64 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.60 |
| ▸ | ATF1 | P18846 | 1/20 | 0.60 |
| ▸ | JAK2 | O60674 | 1/20 | 0.55 |
| ▸ | JAK1 | P23458 | 1/20 | 0.55 |
| ▸ | TYK2 | P29597 | 1/20 | 0.55 |
| ▸ | KCNQ3 | O43525 | 1/20 | 0.54 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.54 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.54 |
| ▸ | KCNQ1 | P51787 | 1/20 | 0.54 |
| ▸ | NR3C1 | P04150 | 5/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | RAB9A | P51151 | 2/20 | 0.52 |
| ▸ | GMNN | O75496 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24823427 | 0.88 | P2RX1 (0.66) | P2RX1P2RX4P2RX7TMPRSS4NFKB1 | |
| SCHEMBL4966684 | 0.88 | NFKB1 (0.58) | P2RX1P2RX4P2RX7TMPRSS4NFKB1 | |
| SCHEMBL5423454 | 0.86 | RAB9A (0.57) | P2RX1P2RX4P2RX7TMPRSS4SMN1; SMN2 | |
| SCHEMBL4967913 | 0.83 | ABL1 (0.64) | NPC1RAB9AMEN1KMT2A | |
| SCHEMBL1585024 | 0.83 | NFKB1 (0.52) | P2RX1P2RX4P2RX7TMPRSS4NFKB1 | |
| SCHEMBL27083743 | 0.81 | TMPRSS4 (0.52) | TMPRSS4KCNQ3KCNQ2KCNE1KCNQ1 | |
| SCHEMBL28049181 | 0.80 | KCNQ3 (0.50) | P2RX1P2RX4P2RX7TMPRSS4NFKB1 | |
| SCHEMBL24684142 | 0.80 | NFKB1 (0.51) | P2RX1P2RX4P2RX7TMPRSS4NFKB1 | |
| SCHEMBL16616963 | 0.80 | MEN1 (0.61) | P2RX1P2RX4P2RX7TMPRSS4NFKB1 | |
| SCHEMBL22892728 | 0.78 | NFKB1 (0.63) | P2RX1P2RX4P2RX7TMPRSS4NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8247556-B2 | Method for preparing 6-substituted-7-aza-indoles | AMGEN INC. (US) | 2012-08-21 | — | — | US | disclosed |
| EP-1971604-B1 | PYRROLO-PYRIDINE DERIVATIVES FOR THE TREATMENT OF CANCER DISEASES | AMGEN INC (US) | 2012-08-01 | — | — | EP | disclosed |
| US-20070185171-A1 | Compounds and methods of use | AMGEN INC. | 2007-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070185171-A1 | Compounds and methods of use | VHL, PGF, PTGIS | P2RX1 1373/4885P2RX4 1521/4885P2RX7 1555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.